EHC NYSE Week ended 24 Jul 2026

Weekly Investor Report

Encompass Health Corp · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 112.9 USD
0.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 8.6% above the Trend Line and sits at 58.1% of its 52-week range. The latest completed week returned 0.6%, after a 11.6% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 35/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 53 out of 100
Latest Close 112.9 USD 24 Jul 2026
1W Return 0.6% latest completed week
4W Return 11.6% short-term follow-through
12W Return 5.2% quarterly tape
Trend Breadth 34.6% 18 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.6% Latest completed week; four-week move 11.6%. Indicator stack 29/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 35/100 conviction; expected move 12.0%. News sentiment 55/100 58 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 8.6% above the Trend Line and sits at 58.1% of its 52-week range. The latest completed week returned 0.6%, after a 11.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3712-week average 0.19

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 11.6% over four weeks, 5.2% over 12 weeks, and 5.4% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W0.6%
4W11.6%
12W5.2%
26W14.9%
52W5.4%
Active trend streak3 weeks
Active weeks in one year18
Trend breadth34.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.24Latest activity-pressure read.
Pressure change565.3%Four-week change in activity pressure.
Leadership-5.07Latest relative-leadership reading.
RS change66.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength83/100Blend of value, momentum, and quality. Underlying universe rank 18; rank 1 is best.
Value71/100Relative valuation strength. Underlying universe rank 30; rank 1 is best.
Quality98/100Profitability and accounting quality. Underlying universe rank 3; rank 1 is best.
Momentum29/100Medium-term price momentum. Underlying universe rank 72; rank 1 is best.
Growth81/100Revenue and earnings growth. Underlying universe rank 20; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework71/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.4x
Price divided by trailing earnings.
Price / sales
1.8x
Market value relative to trailing revenue.
EV / EBITDA
10.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
13.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
58.8%
Gross profit retained from each unit of revenue.
Operating margin
18.6%
Operating profit retained from revenue.
Free-cash-flow margin
31.9%
Free cash flow generated from revenue.
Return on invested capital
17.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.0%
Latest one-year revenue growth.
EPS growth
23.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
12.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
9/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.7%
Cash dividends relative to market value.
Buyback yield
1.8%
Net share repurchases relative to market value.
Shareholder yield
2.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

EHC shows bullish options pressure with a 35/100 conviction score, put-call volume ratio of 0.80, expected move of 12.0%, and Sharemaestro trend signal active.

Conviction35/100
Expected move12.0%
Put/call volume0.80
Pressure19
Speculation20
Volatility43
Trend agreement70
Open options detail
Insider activity16 / 4

16 acquisitions and 4 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 58 relevant articles.

18 positive · 38 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move12.0%Nearest-chain priced movement where available.
52-week drawdown-11.5%Distance below the 52-week high.
13-week volatility2.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+11.5%Week of 6 Feb.
Worst week-6.2%Week of 13 Mar.
Latest week+0.6%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains9
Flat weeks0
Modest losses9
Sharp losses3
Recent vol2.8%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis40/100

Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.37; 1 reversal markers Factors71/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 25; Small Cap Core rank 41 SVQF71/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 292.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options59/100

EHC shows bullish options pressure with a 35/100 conviction score, put-call volume ratio of 0.80, expected move of 12.0%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 12.0% Sentiment55/100

Weighted news tone is neutral across 58 relevant articles.

Vanguard Portfolio Management (EHC) discloses 4.97% Encompass Health ownership in 13G/A Insiders16 / 4

16 acquisitions and 4 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026112.9 USD0.6%104.0 USD94.72 USD1.24-5.073.8MOn
17 Jul 2026112.2 USD1.9%103.8 USD94.41 USD1.09-6.395.2MOn
10 Jul 2026110.2 USD3.5%103.6 USD94.11 USD0.70-9.795.4MOn
3 Jul 2026106.5 USD5.3%103.5 USD93.82 USD0.29-12.103.8MOff
26 Jun 2026101.1 USD3.4%103.7 USD93.55 USD0.19-15.179.1MOff
19 Jun 202697.85 USD-3.4%104.1 USD93.33 USD0.10-20.454.6MOff
12 Jun 2026101.3 USD-2.4%104.7 USD93.11 USD0.16-17.573.9MOff
5 Jun 2026103.8 USD-1.7%105.1 USD92.87 USD0.34-15.684.1MOff
29 May 2026105.7 USD0.8%105.4 USD92.60 USD0.51-16.942.7MOff
22 May 2026104.8 USD-1.6%105.7 USD92.32 USD0.65-17.073.7MOff
15 May 2026106.4 USD0.5%106.4 USD92.02 USD0.68-15.644.0MOff
8 May 2026105.9 USD-1.3%107.0 USD91.73 USD0.62-16.465.6MOff
1 May 2026107.3 USD5.2%107.5 USD91.43 USD0.55-13.996.8MOff
24 Apr 2026102.0 USD-4.1%108.0 USD91.14 USD0.21-18.004.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.